New insights into the burden and costs of multiple sclerosis in Europe
The current focus in multiple sclerosis (MS) is on early diagnosis and drug intervention, with a view to modifying disease progression. Consequently, healthcare costs have shifted from inpatient care and rehabilitation to outpatient care. This European burden of illness study provides data that can...
Uloženo v:
| Vydáno v: | Multiple sclerosis Ročník 23; číslo 8; s. 1123 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
01.07.2017
|
| Témata: | |
| ISSN: | 1477-0970, 1477-0970 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The current focus in multiple sclerosis (MS) is on early diagnosis and drug intervention, with a view to modifying disease progression. Consequently, healthcare costs have shifted from inpatient care and rehabilitation to outpatient care.
This European burden of illness study provides data that can be combined with other evidence to assess whether management approaches provide value to society.
A cross-sectional study was conducted in 16 countries. Patients reported on their disease, health-related quality of life (HRQoL) and resource consumption. Descriptive analyses were performed by disease severity. Costs are reported from a societal perspective in 2015€ PPP (adjusted for purchasing power parity).
The 16,808 participants had a mean age of 51.5 years, and 52% had relapsing-remitting multiple sclerosis (RRMS). Work capacity declined from 82% to 8%, and utility declined from normal population values to less than zero with advancing disease. Mean costs were 22,800€ PPP in mild, 37,100€ PPP in moderate and 57,500€ PPP in severe disease; healthcare accounted for 68%, 47% and 26%, respectively. Fatigue and cognitive difficulties were reported by 95% and 71% of participants, respectively; both had a significant independent effect on utility.
Costs and utility were highly correlated with disease severity, but resource consumption was heavily influenced by healthcare systems organisation and availability of services. |
|---|---|
| AbstractList | The current focus in multiple sclerosis (MS) is on early diagnosis and drug intervention, with a view to modifying disease progression. Consequently, healthcare costs have shifted from inpatient care and rehabilitation to outpatient care.BACKGROUNDThe current focus in multiple sclerosis (MS) is on early diagnosis and drug intervention, with a view to modifying disease progression. Consequently, healthcare costs have shifted from inpatient care and rehabilitation to outpatient care.This European burden of illness study provides data that can be combined with other evidence to assess whether management approaches provide value to society.OBJECTIVESThis European burden of illness study provides data that can be combined with other evidence to assess whether management approaches provide value to society.A cross-sectional study was conducted in 16 countries. Patients reported on their disease, health-related quality of life (HRQoL) and resource consumption. Descriptive analyses were performed by disease severity. Costs are reported from a societal perspective in 2015€ PPP (adjusted for purchasing power parity).METHODSA cross-sectional study was conducted in 16 countries. Patients reported on their disease, health-related quality of life (HRQoL) and resource consumption. Descriptive analyses were performed by disease severity. Costs are reported from a societal perspective in 2015€ PPP (adjusted for purchasing power parity).The 16,808 participants had a mean age of 51.5 years, and 52% had relapsing-remitting multiple sclerosis (RRMS). Work capacity declined from 82% to 8%, and utility declined from normal population values to less than zero with advancing disease. Mean costs were 22,800€ PPP in mild, 37,100€ PPP in moderate and 57,500€ PPP in severe disease; healthcare accounted for 68%, 47% and 26%, respectively. Fatigue and cognitive difficulties were reported by 95% and 71% of participants, respectively; both had a significant independent effect on utility.RESULTSThe 16,808 participants had a mean age of 51.5 years, and 52% had relapsing-remitting multiple sclerosis (RRMS). Work capacity declined from 82% to 8%, and utility declined from normal population values to less than zero with advancing disease. Mean costs were 22,800€ PPP in mild, 37,100€ PPP in moderate and 57,500€ PPP in severe disease; healthcare accounted for 68%, 47% and 26%, respectively. Fatigue and cognitive difficulties were reported by 95% and 71% of participants, respectively; both had a significant independent effect on utility.Costs and utility were highly correlated with disease severity, but resource consumption was heavily influenced by healthcare systems organisation and availability of services.CONCLUSIONCosts and utility were highly correlated with disease severity, but resource consumption was heavily influenced by healthcare systems organisation and availability of services. The current focus in multiple sclerosis (MS) is on early diagnosis and drug intervention, with a view to modifying disease progression. Consequently, healthcare costs have shifted from inpatient care and rehabilitation to outpatient care. This European burden of illness study provides data that can be combined with other evidence to assess whether management approaches provide value to society. A cross-sectional study was conducted in 16 countries. Patients reported on their disease, health-related quality of life (HRQoL) and resource consumption. Descriptive analyses were performed by disease severity. Costs are reported from a societal perspective in 2015€ PPP (adjusted for purchasing power parity). The 16,808 participants had a mean age of 51.5 years, and 52% had relapsing-remitting multiple sclerosis (RRMS). Work capacity declined from 82% to 8%, and utility declined from normal population values to less than zero with advancing disease. Mean costs were 22,800€ PPP in mild, 37,100€ PPP in moderate and 57,500€ PPP in severe disease; healthcare accounted for 68%, 47% and 26%, respectively. Fatigue and cognitive difficulties were reported by 95% and 71% of participants, respectively; both had a significant independent effect on utility. Costs and utility were highly correlated with disease severity, but resource consumption was heavily influenced by healthcare systems organisation and availability of services. |
| Author | Eriksson, Jennifer Kobelt, Gisela Berg, Jenny Gannedahl, Mia Thompson, Alan |
| Author_xml | – sequence: 1 givenname: Gisela surname: Kobelt fullname: Kobelt, Gisela organization: European Health Economics, Mulhouse, France – sequence: 2 givenname: Alan surname: Thompson fullname: Thompson, Alan organization: Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK – sequence: 3 givenname: Jenny surname: Berg fullname: Berg, Jenny organization: Mapi Group, Stockholm, Sweden – sequence: 4 givenname: Mia surname: Gannedahl fullname: Gannedahl, Mia organization: Mapi Group, Stockholm, Sweden – sequence: 5 givenname: Jennifer surname: Eriksson fullname: Eriksson, Jennifer organization: Mapi Group, Stockholm, Sweden |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28273775$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj0tLw0AUhQep2IfuXcks3aTOMzezlNKqUOpG1yGZubGRJBMzE8R_b8QKrs4H5-PAWZJZ5zsk5JqzNecAd1xqoXSmOaRGKSnOyIIrgIQZYLN_PCfLEN4ZYwBSX5C5yARIAL0guwN-0roL9dsxhgmip_GItBwHhx0tOketD1PjK9qOTaz7BmmwDQ4-1D8-3Y6D7_GSnFdFE_DqlCvyutu-bB6T_fPD0-Z-n1gtRUy4tgAclExNWmYalSxNxZ0Qik19CqCMU67ghhmj0YlST2izSpeV1VYYsSK3v7v94D9GDDFv62CxaYoO_RhynkGqTCo4TOrNSR3LFl3eD3VbDF_533fxDVZTW6A |
| CitedBy_id | crossref_primary_10_7759_cureus_74001 crossref_primary_10_1007_s12325_020_01570_0 crossref_primary_10_1177_1352458517708668 crossref_primary_10_3390_s23115251 crossref_primary_10_1177_1352458517708666 crossref_primary_10_1177_1352458517708667 crossref_primary_10_1088_2057_1976_ace261 crossref_primary_10_1177_1352458517708672 crossref_primary_10_1007_s10072_018_3550_8 crossref_primary_10_1016_j_msard_2023_105140 crossref_primary_10_1038_s41598_023_28990_6 crossref_primary_10_1016_j_jns_2023_120833 crossref_primary_10_1016_S1474_4422_22_00255_1 crossref_primary_10_3389_fncel_2018_00114 crossref_primary_10_1016_j_mehy_2022_110863 crossref_primary_10_1002_acn3_70130 crossref_primary_10_1080_09638288_2024_2350618 crossref_primary_10_1016_j_msard_2024_105774 crossref_primary_10_1186_s13643_022_01997_2 crossref_primary_10_1186_s13690_021_00561_z crossref_primary_10_1016_j_heliyon_2025_e42693 crossref_primary_10_1038_s41598_024_62736_2 crossref_primary_10_1007_s15005_022_3002_0 crossref_primary_10_1136_jnnp_2017_317509 crossref_primary_10_1177_1352458517708685 crossref_primary_10_1177_1352458517708682 crossref_primary_10_1007_s11136_025_03970_7 crossref_primary_10_1080_13854046_2024_2348831 crossref_primary_10_1016_j_neurol_2021_06_009 crossref_primary_10_1177_13524585211048759 crossref_primary_10_1080_09638288_2021_1919929 crossref_primary_10_1080_14656566_2019_1615880 crossref_primary_10_3389_fneur_2019_00581 crossref_primary_10_1111_ene_13536 crossref_primary_10_3233_THC_230541 crossref_primary_10_1136_bmjopen_2024_094418 crossref_primary_10_1016_j_ailsci_2022_100042 crossref_primary_10_1016_j_ncl_2024_05_010 crossref_primary_10_1016_j_vhri_2025_101096 crossref_primary_10_1007_s40120_025_00761_7 crossref_primary_10_1055_a_1903_4483 crossref_primary_10_1186_s12883_023_03078_w crossref_primary_10_1089_pop_2021_0040 crossref_primary_10_1155_2019_2027947 crossref_primary_10_1177_20552076251326230 crossref_primary_10_1016_j_cca_2022_01_017 crossref_primary_10_1177_1352458520938990 crossref_primary_10_1177_1352458517708687 crossref_primary_10_1016_j_heliyon_2024_e35753 crossref_primary_10_1111_jnp_12202 crossref_primary_10_1007_s12035_022_03060_6 crossref_primary_10_1016_j_jpainsymman_2024_01_006 crossref_primary_10_1016_j_msard_2021_103432 crossref_primary_10_1007_s11136_025_03928_9 crossref_primary_10_1080_14737167_2023_2184802 crossref_primary_10_1016_j_apmr_2020_12_002 crossref_primary_10_1016_j_msard_2018_04_003 crossref_primary_10_1177_13524585241245318 crossref_primary_10_1186_s41983_025_00955_8 crossref_primary_10_3389_fneur_2023_1157287 crossref_primary_10_1080_09638288_2020_1731853 crossref_primary_10_1177_1352458517708100 crossref_primary_10_4103_1673_5374_358612 crossref_primary_10_1016_j_msard_2020_102046 crossref_primary_10_1080_03007995_2021_1904860 crossref_primary_10_1016_j_msard_2020_102162 crossref_primary_10_1177_13524585221081985 crossref_primary_10_1177_1352458517751049 crossref_primary_10_1177_17562864241273045 crossref_primary_10_1016_j_msard_2019_01_045 crossref_primary_10_1088_1741_2552_adf010 crossref_primary_10_1007_s40120_020_00176_6 crossref_primary_10_2196_17921 crossref_primary_10_1016_j_msard_2021_102756 crossref_primary_10_1080_01616412_2021_1893567 crossref_primary_10_3389_fresc_2024_1404723 crossref_primary_10_1007_s12035_020_02017_x crossref_primary_10_1097_JNN_0000000000000713 crossref_primary_10_1111_jon_70005 crossref_primary_10_1016_j_msard_2020_102358 crossref_primary_10_1177_1352458519893926 crossref_primary_10_1016_j_ctim_2019_07_016 crossref_primary_10_1016_j_msard_2020_102354 crossref_primary_10_3389_fneur_2022_1015256 crossref_primary_10_1007_s40120_022_00358_4 crossref_primary_10_3389_fneur_2021_647811 crossref_primary_10_1177_13524585241287388 crossref_primary_10_3389_fneur_2021_737211 crossref_primary_10_1016_j_msard_2019_01_056 crossref_primary_10_1177_1352458520910499 crossref_primary_10_3390_ijms241713479 crossref_primary_10_1016_j_msard_2022_103834 crossref_primary_10_1016_j_msard_2022_103955 crossref_primary_10_4103_ATMR_ATMR_101_24 crossref_primary_10_1177_1352458521999970 crossref_primary_10_1002_hsr2_474 crossref_primary_10_3390_biom12030344 crossref_primary_10_21020_husbfd_1001761 crossref_primary_10_1007_s00415_019_09311_2 crossref_primary_10_1016_j_msard_2022_103707 crossref_primary_10_1177_20552173241293921 crossref_primary_10_1007_s40263_018_0530_8 crossref_primary_10_3390_jcm11040942 crossref_primary_10_1055_a_1471_3636 crossref_primary_10_1007_s00415_025_12906_7 crossref_primary_10_3389_fimmu_2024_1362629 crossref_primary_10_1017_cjn_2024_288 crossref_primary_10_1111_ene_14823 crossref_primary_10_1016_j_mcna_2024_09_011 crossref_primary_10_1080_09638288_2018_1470262 crossref_primary_10_1080_21679169_2024_2385325 crossref_primary_10_1002_brb3_2582 crossref_primary_10_1111_ene_14824 crossref_primary_10_1038_s41598_021_87941_1 crossref_primary_10_1186_s41983_024_00904_x crossref_primary_10_1016_j_msard_2021_102778 crossref_primary_10_1016_j_rehab_2021_101529 crossref_primary_10_1016_j_msard_2022_103704 crossref_primary_10_1080_09593985_2023_2299726 crossref_primary_10_1007_s00415_024_12305_4 crossref_primary_10_7759_cureus_44810 crossref_primary_10_1007_s10072_018_3551_7 crossref_primary_10_3390_ijerph19063271 crossref_primary_10_7759_cureus_83386 crossref_primary_10_1177_13524585221137697 crossref_primary_10_1186_s12883_019_1495_z crossref_primary_10_1016_j_msard_2019_101514 crossref_primary_10_1016_j_msard_2019_101877 crossref_primary_10_1136_bmjopen_2020_045378 crossref_primary_10_1016_j_cmpb_2022_106900 crossref_primary_10_1212_NXI_0000000000000745 crossref_primary_10_1177_20552173221090653 crossref_primary_10_33715_inonusaglik_1379379 crossref_primary_10_1016_j_nicl_2024_103651 crossref_primary_10_1177_1352458517708663 crossref_primary_10_1055_a_2034_4371 crossref_primary_10_1016_j_msard_2020_102247 crossref_primary_10_1016_j_seizure_2023_12_020 crossref_primary_10_1080_01616412_2025_2537328 crossref_primary_10_1186_s12955_024_02278_3 crossref_primary_10_57264_cer_2022_0175 crossref_primary_10_2147_PRBM_S310664 crossref_primary_10_1016_j_msard_2021_103361 crossref_primary_10_1016_j_msard_2021_103482 crossref_primary_10_3389_fneur_2021_675244 crossref_primary_10_3390_pharmaceutics15030728 crossref_primary_10_1007_s15202_017_1790_8 crossref_primary_10_1007_s10198_019_01058_x crossref_primary_10_2196_19230 crossref_primary_10_1080_14737167_2020_1722103 crossref_primary_10_3390_biomedicines11113069 crossref_primary_10_1002_cbic_202300444 crossref_primary_10_1016_j_brain_2024_100097 crossref_primary_10_1177_1352458518777377 crossref_primary_10_1016_j_msard_2025_106767 crossref_primary_10_1111_iji_12465 crossref_primary_10_1017_cjn_2022_309 crossref_primary_10_1016_j_jcbs_2021_07_001 crossref_primary_10_1177_20552076221135387 crossref_primary_10_3390_sci3010012 crossref_primary_10_1016_j_msard_2025_106763 crossref_primary_10_2217_nmt_2021_0016 crossref_primary_10_1016_j_msard_2021_103138 crossref_primary_10_1016_j_msard_2022_103756 crossref_primary_10_1038_s41746_024_01025_8 crossref_primary_10_3390_antiox13080914 crossref_primary_10_1371_journal_pone_0234876 crossref_primary_10_1186_s41983_021_00419_9 crossref_primary_10_1016_j_msard_2021_103261 crossref_primary_10_1007_s40273_020_00917_3 crossref_primary_10_3390_jcm10225401 crossref_primary_10_1177_20552076221117740 crossref_primary_10_1016_j_msard_2022_103864 crossref_primary_10_1007_s40273_025_01486_z crossref_primary_10_1080_14737167_2023_2251689 crossref_primary_10_7224_1537_2073_2018_068 crossref_primary_10_1016_j_ab_2025_115781 crossref_primary_10_1007_s10528_025_11077_4 crossref_primary_10_1186_s41983_021_00376_3 crossref_primary_10_1016_j_neurol_2023_12_007 crossref_primary_10_1177_1352458517708176 crossref_primary_10_1111_ene_13819 crossref_primary_10_1177_2055217320902481 crossref_primary_10_1186_s12955_025_02376_w crossref_primary_10_1186_s12967_025_06296_7 crossref_primary_10_1016_j_msard_2021_103398 crossref_primary_10_1212_NXI_0000000000000548 crossref_primary_10_1007_s10072_022_06517_7 crossref_primary_10_1016_j_msard_2022_103971 crossref_primary_10_2217_nmt_2021_0038 crossref_primary_10_1007_s40273_018_0683_9 crossref_primary_10_1007_s10198_017_0894_6 crossref_primary_10_1016_j_mito_2024_102002 crossref_primary_10_1186_s12913_022_08883_6 crossref_primary_10_7224_1537_2073_2018_053 crossref_primary_10_1007_s40273_021_01106_6 crossref_primary_10_1002_hbm_25839 crossref_primary_10_1371_journal_pone_0259855 crossref_primary_10_1016_j_nrl_2021_01_012 crossref_primary_10_3233_NRE_210179 crossref_primary_10_1007_s10565_023_09820_x crossref_primary_10_1177_1352458518769837 crossref_primary_10_1016_j_msard_2022_103687 crossref_primary_10_1016_j_msard_2021_103326 crossref_primary_10_1007_s12031_024_02269_5 crossref_primary_10_3390_biomedicines11020353 crossref_primary_10_1055_a_1824_6238 crossref_primary_10_7759_cureus_92027 crossref_primary_10_1016_j_msard_2025_106673 crossref_primary_10_1016_j_brainresbull_2020_10_015 crossref_primary_10_1111_ane_13664 crossref_primary_10_1007_s11910_019_1002_3 crossref_primary_10_1177_10519815241292163 crossref_primary_10_1136_bmjopen_2020_043699 crossref_primary_10_1177_1352458517708118 crossref_primary_10_1177_20552173211022782 crossref_primary_10_1177_1352458520923945 crossref_primary_10_1177_1352458517708117 crossref_primary_10_1136_bmjopen_2020_042480 crossref_primary_10_3390_ijms21051663 crossref_primary_10_1177_2055217317730421 crossref_primary_10_3390_sclerosis3020014 crossref_primary_10_1016_j_jns_2019_07_009 crossref_primary_10_1111_ane_13411 crossref_primary_10_29254_2077_4214_2022_2_1_164_145_157 crossref_primary_10_1016_S0140_6736_18_30481_1 crossref_primary_10_3389_fneur_2020_574748 crossref_primary_10_1016_j_msard_2025_106456 crossref_primary_10_26599_FSHW_2024_9250215 crossref_primary_10_1007_s00739_017_0437_z crossref_primary_10_1007_s11910_020_01043_5 crossref_primary_10_1016_j_ejphar_2025_177647 crossref_primary_10_1007_s10926_023_10149_9 crossref_primary_10_1093_brain_awz234 crossref_primary_10_1007_s40120_023_00523_3 crossref_primary_10_1111_aos_14463 crossref_primary_10_3233_WOR_213446 crossref_primary_10_1177_1352458517703804 crossref_primary_10_1016_j_msard_2021_103112 crossref_primary_10_1177_2055217318783352 crossref_primary_10_1016_j_msard_2021_103355 crossref_primary_10_1016_j_msard_2024_106169 crossref_primary_10_1016_j_msard_2025_106466 crossref_primary_10_1111_joim_13215 crossref_primary_10_3390_pharmacy8020061 crossref_primary_10_1891_JARC_2021_0018 crossref_primary_10_1016_S1474_4422_19_30190_5 crossref_primary_10_1212_WNL_0000000000209351 crossref_primary_10_1016_j_msard_2023_104918 crossref_primary_10_1177_1352458517708141 crossref_primary_10_1177_1352458517708142 crossref_primary_10_3390_cells13030217 crossref_primary_10_1016_j_msard_2025_106342 crossref_primary_10_1016_j_msard_2024_106161 crossref_primary_10_1093_braincomms_fcaf223 crossref_primary_10_1016_j_msard_2022_104457 crossref_primary_10_1177_13524585221148094 crossref_primary_10_1007_s41669_023_00394_2 crossref_primary_10_3390_ph15091077 crossref_primary_10_1016_j_msard_2023_104734 crossref_primary_10_3390_pr11020319 crossref_primary_10_1080_14737167_2022_2008242 crossref_primary_10_1007_s41669_019_0150_3 crossref_primary_10_1016_j_jneumeth_2021_109443 crossref_primary_10_57264_cer_2023_0016 crossref_primary_10_1186_s12913_017_2807_x crossref_primary_10_3390_diagnostics13193030 crossref_primary_10_1080_14737167_2021_1945926 crossref_primary_10_1007_s00415_024_12729_y crossref_primary_10_1016_j_msard_2024_106194 crossref_primary_10_1080_23279095_2023_2233648 crossref_primary_10_2174_1871524921666210127110028 crossref_primary_10_3389_fneur_2022_1062847 crossref_primary_10_1007_s10072_019_03780_z crossref_primary_10_1111_ene_16234 crossref_primary_10_1111_ene_15030 crossref_primary_10_1177_13524585221116269 crossref_primary_10_3389_fnins_2021_679941 crossref_primary_10_1016_j_ajo_2023_01_015 crossref_primary_10_1016_j_msard_2019_03_011 crossref_primary_10_3390_ijerph17103388 crossref_primary_10_1007_s00115_021_01073_5 crossref_primary_10_1016_j_neurol_2025_02_005 crossref_primary_10_1016_j_msard_2018_09_018 crossref_primary_10_7224_1537_2073_2023_010 crossref_primary_10_1212_WNL_0000000000207768 crossref_primary_10_1016_j_neuroimage_2022_119787 crossref_primary_10_1016_j_bbmt_2019_02_014 crossref_primary_10_1007_s10072_022_06524_8 crossref_primary_10_2196_10951 crossref_primary_10_3390_healthcare9070897 crossref_primary_10_1177_13524585251328556 crossref_primary_10_3390_brainsci15080807 crossref_primary_10_1016_j_msard_2023_104841 crossref_primary_10_1080_14737175_2018_1510772 crossref_primary_10_3390_biomedicines11020603 crossref_primary_10_1371_journal_pone_0264123 crossref_primary_10_3390_jcm14020373 crossref_primary_10_1080_09638288_2018_1461937 crossref_primary_10_1111_ene_16495 crossref_primary_10_3389_fcell_2025_1517369 crossref_primary_10_2217_nmt_2020_0054 crossref_primary_10_3390_medicina58070948 crossref_primary_10_1016_j_msard_2017_07_010 crossref_primary_10_1590_1518_8345_3068_3183 crossref_primary_10_1016_j_msard_2019_101396 crossref_primary_10_1371_journal_pone_0267504 crossref_primary_10_1177_13524585221089900 crossref_primary_10_1136_jnnp_2018_318866 crossref_primary_10_3390_ijerph19010199 crossref_primary_10_5604_01_3001_0013_0543 crossref_primary_10_1080_09638288_2023_2237403 crossref_primary_10_1007_s10198_022_01540_z crossref_primary_10_3389_fnins_2021_742065 crossref_primary_10_1111_ene_16547 crossref_primary_10_1016_j_msard_2022_104016 crossref_primary_10_3389_fneur_2024_1295770 crossref_primary_10_1186_s12913_025_12592_1 crossref_primary_10_1007_s00281_020_00822_z crossref_primary_10_61882_shefa_13_3_12 crossref_primary_10_1080_14737175_2019_1632192 crossref_primary_10_1007_s00739_022_00779_8 crossref_primary_10_1080_09638288_2025_2552871 crossref_primary_10_1177_17562864231198963 crossref_primary_10_3389_fneur_2020_00900 crossref_primary_10_1155_2019_7290285 crossref_primary_10_1111_ene_14012 crossref_primary_10_3390_ijms25010261 crossref_primary_10_1096_fj_202401764R crossref_primary_10_1145_3478098 crossref_primary_10_1007_s10926_025_10279_2 crossref_primary_10_1016_S1474_4422_20_30342_2 crossref_primary_10_3389_fpsyt_2020_00811 crossref_primary_10_1007_s00115_021_01118_9 crossref_primary_10_1177_20552173221093219 crossref_primary_10_1177_1352458519851212 crossref_primary_10_1177_1352458517702549 crossref_primary_10_1016_j_msard_2023_104997 crossref_primary_10_1186_s13643_021_01751_0 crossref_primary_10_1055_s_0045_1809400 crossref_primary_10_1016_j_jneuroim_2020_577163 crossref_primary_10_3389_fneur_2021_693017 crossref_primary_10_1080_14737167_2017_1358617 crossref_primary_10_3389_fneur_2023_1214897 crossref_primary_10_1177_1756286420975223 crossref_primary_10_1186_s13023_021_01694_8 crossref_primary_10_1177_1352458517708099 crossref_primary_10_1177_1352458517708097 crossref_primary_10_1177_1352458517708096 crossref_primary_10_1007_s40273_021_01032_7 crossref_primary_10_3390_diagnostics11081424 crossref_primary_10_1002_iid3_1213 crossref_primary_10_1016_j_jval_2018_08_002 crossref_primary_10_1177_16094069231180162 crossref_primary_10_1177_1352458519895450 crossref_primary_10_1080_14737175_2020_1838276 crossref_primary_10_3389_fnmol_2022_894298 crossref_primary_10_1016_j_msard_2023_104525 crossref_primary_10_1007_s12016_020_08796_4 crossref_primary_10_1038_s41572_018_0041_4 crossref_primary_10_1186_s12889_019_6907_x crossref_primary_10_1002_ccr3_7548 crossref_primary_10_1007_s11553_021_00900_6 crossref_primary_10_1177_20552173221085741 crossref_primary_10_1016_j_msard_2019_05_024 crossref_primary_10_1016_j_apmr_2025_02_011 crossref_primary_10_3390_healthcare11172398 crossref_primary_10_1007_s40261_020_00895_6 crossref_primary_10_1136_bmjopen_2024_086414 crossref_primary_10_1177_2055217320901727 crossref_primary_10_3390_bioengineering10010041 crossref_primary_10_1016_j_msard_2021_102835 crossref_primary_10_1007_s00228_024_03783_6 crossref_primary_10_1016_j_msard_2020_102559 crossref_primary_10_1007_s12325_019_01148_5 crossref_primary_10_1111_ene_70140 crossref_primary_10_1177_13524585221074010 crossref_primary_10_3389_fimmu_2022_869447 crossref_primary_10_1186_s12883_018_1175_4 crossref_primary_10_1177_1352458517737388 crossref_primary_10_1038_s41598_025_87827_6 crossref_primary_10_1186_s12913_024_10851_1 crossref_primary_10_1007_s00415_024_12736_z crossref_primary_10_1016_j_msard_2022_104166 crossref_primary_10_1002_glia_23820 crossref_primary_10_1159_000513234 crossref_primary_10_7224_1537_2073_2023_060 crossref_primary_10_3390_ijms24032831 crossref_primary_10_1007_s43440_025_00725_6 crossref_primary_10_1007_s00415_021_10400_4 crossref_primary_10_1016_j_msard_2020_102539 crossref_primary_10_1177_20552173231187810 crossref_primary_10_1186_s12889_024_18844_9 crossref_primary_10_1007_s10072_024_07790_4 crossref_primary_10_1371_journal_pone_0204681 crossref_primary_10_1016_j_msard_2020_102420 crossref_primary_10_1097_MD_0000000000016043 crossref_primary_10_3390_su13084517 crossref_primary_10_1016_j_msard_2018_10_109 crossref_primary_10_1007_s10072_020_04841_4 crossref_primary_10_1016_j_msard_2019_101424 crossref_primary_10_1007_s00415_024_12723_4 crossref_primary_10_1177_13524585251334488 crossref_primary_10_1186_s12883_020_01790_5 crossref_primary_10_1177_1352458519898590 crossref_primary_10_3389_fneur_2023_1086720 crossref_primary_10_1016_j_nrleng_2021_01_009 crossref_primary_10_1371_journal_pone_0199446 crossref_primary_10_1007_s40259_020_00414_1 crossref_primary_10_1016_j_msard_2020_102212 crossref_primary_10_3390_biology11010147 crossref_primary_10_3390_immuno2030029 crossref_primary_10_1016_j_imlet_2020_02_012 crossref_primary_10_1016_j_msard_2021_102860 crossref_primary_10_1007_s13760_023_02225_x crossref_primary_10_1371_journal_pone_0216646 crossref_primary_10_1016_j_msard_2021_102741 crossref_primary_10_3390_ijms23063349 crossref_primary_10_1016_j_msard_2019_08_003 crossref_primary_10_1002_ejoc_202401381 crossref_primary_10_1080_11038128_2019_1634149 crossref_primary_10_1177_10538135251336067 crossref_primary_10_1080_14737167_2022_1987218 crossref_primary_10_3390_brainsci12040476 crossref_primary_10_1016_j_msard_2020_102444 crossref_primary_10_1007_s00234_024_03439_3 crossref_primary_10_3390_ijerph17030886 crossref_primary_10_1007_s12017_024_08783_4 crossref_primary_10_1016_j_msard_2020_102563 crossref_primary_10_1007_s40273_021_01023_8 crossref_primary_10_1007_s00415_024_12395_0 crossref_primary_10_1136_bmjopen_2024_085241 crossref_primary_10_1177_1756286420960274 crossref_primary_10_1212_WNL_0000000000008667 crossref_primary_10_1016_j_msard_2023_105100 crossref_primary_10_1186_s12883_021_02447_7 crossref_primary_10_1016_j_intimp_2023_110787 crossref_primary_10_1016_j_msard_2023_105345 crossref_primary_10_54101_ACEN_2023_2_9 crossref_primary_10_1016_S0140_6736_23_01473_3 crossref_primary_10_1016_j_nbd_2022_105950 crossref_primary_10_1016_j_msard_2024_105507 crossref_primary_10_1136_bmjopen_2017_020392 crossref_primary_10_1159_000488799 crossref_primary_10_1016_j_msard_2020_102512 crossref_primary_10_1007_s40273_021_01035_4 crossref_primary_10_1371_journal_pone_0208837 crossref_primary_10_1016_j_apmr_2021_03_026 crossref_primary_10_1016_j_msard_2018_06_016 crossref_primary_10_1186_s12913_020_4946_8 crossref_primary_10_3390_pharmaceutics15041151 crossref_primary_10_1177_17562864241237857 crossref_primary_10_1177_20552173221092411 crossref_primary_10_1007_s10198_022_01471_9 crossref_primary_10_1177_1352458519887897 crossref_primary_10_3390_ijms22168370 crossref_primary_10_1016_j_ijporl_2020_110048 crossref_primary_10_33438_ijdshs_1294268 crossref_primary_10_1111_ejn_16253 crossref_primary_10_52711_0974_360X_2023_00248 crossref_primary_10_2196_25011 crossref_primary_10_1007_s40120_023_00475_8 crossref_primary_10_33808_clinexphealthsci_943059 crossref_primary_10_1007_s41669_024_00501_x crossref_primary_10_1186_s12883_021_02193_w crossref_primary_10_1007_s40120_019_00172_5 crossref_primary_10_1016_j_msard_2024_105645 crossref_primary_10_4103_NRR_NRR_D_24_01371 crossref_primary_10_1177_2055217319858383 crossref_primary_10_1186_s12913_020_05664_x crossref_primary_10_3390_neurosci6030082 crossref_primary_10_1016_j_jocn_2025_111437 crossref_primary_10_1016_j_msard_2020_102416 crossref_primary_10_1111_cts_13108 crossref_primary_10_1177_1756286418759189 crossref_primary_10_1016_j_jns_2018_02_045 crossref_primary_10_1186_s12883_019_1441_0 crossref_primary_10_3389_fneur_2019_00253 crossref_primary_10_7224_1537_2073_2022_083 crossref_primary_10_1016_j_jneuroim_2024_578368 crossref_primary_10_1016_j_lanepe_2024_100977 crossref_primary_10_1016_j_msard_2024_105635 crossref_primary_10_1080_00325481_2024_2441105 crossref_primary_10_1016_j_bbih_2022_100484 crossref_primary_10_1038_s41598_021_86347_3 crossref_primary_10_1080_10641955_2021_1921792 crossref_primary_10_3389_fimmu_2023_1216310 crossref_primary_10_2196_30617 crossref_primary_10_1186_s12911_021_01479_w crossref_primary_10_1002_chem_202404742 crossref_primary_10_1016_j_msard_2018_12_030 crossref_primary_10_1016_j_jval_2022_03_010 |
| ContentType | Journal Article |
| CorporateAuthor | MSCOI Study Group European Multiple Sclerosis Platform |
| CorporateAuthor_xml | – name: European Multiple Sclerosis Platform – name: MSCOI Study Group |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1177/1352458517694432 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1477-0970 |
| ExternalDocumentID | 28273775 |
| Genre | Journal Article |
| GroupedDBID | --- -TM .2E .2F .2G .2J .2N 01A 0R~ 123 18M 1~K 29M 31R 31S 31U 31X 31Y 31Z 36B 39C 3V. 4.4 53G 54M 5VS 7X7 88E 8FI 8FJ 8R4 8R5 AABMB AABOD AACKU AACMV AACTG AADTT AADUE AAEWN AAGGD AAGMC AAJIQ AAJOX AAJPV AAKGS AAMGE AANSI AAPEO AAQDB AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAXOT AAYTG AAZBJ ABAFQ ABAWC ABAWP ABCCA ABCJG ABDWY ABEIX ABFWQ ABHFT ABHKI ABHQH ABJIS ABJNI ABKRH ABLUO ABNCE ABPGX ABPNF ABQKF ABQXT ABRHV ABUJY ABUWG ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLHI ACLZU ACNXM ACOFE ACOXC ACPRK ACROE ACRPL ACSBE ACSIQ ACTQU ACUAV ACUIR ACXKE ACXMB ADBBV ADEIA ADMPF ADNBR ADNMO ADNON ADRRZ ADTBJ ADUCT ADUKL ADVBO ADYCS ADZYD ADZZY AECGH AECVZ AEDTQ AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEUIJ AEWDL AEWHI AEXFG AEXNY AFEET AFKBI AFKRA AFKRG AFMOU AFQAA AFUIA AFVCE AFWMB AGHKR AGKLV AGNHF AGPXR AGWFA AGWNL AHDMH AHHFK AHMBA AIGRN AIOMO AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ AJXGE ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV ASPBG AUTPY AVWKF AYAKG AZFZN AZQEC B3H B8M B8O B8R B8Z B93 B94 BBRGL BDDNI BENPR BKIIM BKNYI BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD BYIEH CAG CBRKF CCPQU CDWPY CFDXU CGR COF CORYS CQQTX CS3 CUTAK CUY CVF DB0 DC- DC0 DD- DD0 DE- DF0 DO- DOPDO DU5 DV7 DV9 D~Y EBS ECM EIF EJD EMOBN ESX F5P FD6 FEDTE FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HMCUK HVGLF HZ~ J8X K.F K.J K9- M0R M1P M4V N9A NPM O9- P.B P2P PQQKQ PROAC PSQYO Q1R Q2X Q7K Q7L Q7R Q7U Q7X Q82 Q83 ROL S01 SAUOL SCNPE SDB SFB SFC SFK SFN SFT SGA SGO SGP SGR SGV SGX SGZ SHG SNB SPJ SPQ SPV SQCSI STM UKHRP XJT ZONMY ZPPRI ZRKOI ZSSAH 7X8 AAPII ABIDT ABJZC ADDLC ADEBD AJGYC AJHME AJVBE SASJQ |
| ID | FETCH-LOGICAL-c532t-15c771743696b85e43b9f1d224053267749d4da190995ed2b5190c8f5bfc5c292 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 531 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000403588100049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1477-0970 |
| IngestDate | Thu Oct 02 04:47:09 EDT 2025 Wed Feb 19 02:35:10 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | costs HRQoL Multiple sclerosis fatigue cognition burden of illness |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c532t-15c771743696b85e43b9f1d224053267749d4da190995ed2b5190c8f5bfc5c292 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://journals.sagepub.com/doi/full/10.1177/1352458517694432 |
| PMID | 28273775 |
| PQID | 1876496217 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1876496217 pubmed_primary_28273775 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-07-01 |
| PublicationDateYYYYMMDD | 2017-07-01 |
| PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Multiple sclerosis |
| PublicationTitleAlternate | Mult Scler |
| PublicationYear | 2017 |
| References | 28504007 - Mult Scler. 2017 Jul;23(8):1048-1049 |
| References_xml | – reference: 28504007 - Mult Scler. 2017 Jul;23(8):1048-1049 |
| SSID | ssj0007735 |
| Score | 2.6566124 |
| Snippet | The current focus in multiple sclerosis (MS) is on early diagnosis and drug intervention, with a view to modifying disease progression. Consequently,... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1123 |
| SubjectTerms | Adult Ambulatory Care - economics Cost of Illness Disease Progression Europe Female Health Care Costs - statistics & numerical data Humans Male Middle Aged Multiple Sclerosis - economics Multiple Sclerosis - epidemiology Multiple Sclerosis - therapy Quality of Life Recurrence Severity of Illness Index |
| Title | New insights into the burden and costs of multiple sclerosis in Europe |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28273775 https://www.proquest.com/docview/1876496217 |
| Volume | 23 |
| WOSCitedRecordID | wos000403588100049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qinjx_VhfRPAatkmTpnMSERcP7rIHlb0taR6wl3a1q7_fSdtlT4LgoaGQJoRhMvPNozOE3CVOcSNyxUSRGzRQEscAZGDWKO8hEUE2pZTeX_R4nE-nMOkcbnWXVrmSiY2gdpWNPvIBx2srIUMEfb_4YLFrVIyudi00NkkvRSgTuVpP19XCtW4abHKpNUtAJ-sw5YAj8JAxJKYzkDI2H_kNYDaKZrj_3yMekL0OYtKHlicOyYYvj8jOqAuiH5MhCjY6L-toltf4sqwookBaND80UFM6aqsaZ6pAV-mGtMadUJ_O4_e09eCfkLfh0-vjM-vaKTCrUrFkXFmtowGSQVbkysu0gMBd1Ok4nyEOBCedQYQAoLwTBYK7xOZBFcEqK0Cckq2yKv05oQl34FPuTSaDNEIYDykUToPB7fDpk9sVhWbIrjEGYUpffdWzNY365Kwl82zR1tWYofWnU63VxR9WX5JdERVskzh7RXoBL6u_Jtv2ezmvP28aPsBxPBn9AJpguu0 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New+insights+into+the+burden+and+costs+of+multiple+sclerosis+in+Europe&rft.jtitle=Multiple+sclerosis&rft.au=Kobelt%2C+Gisela&rft.au=Thompson%2C+Alan&rft.au=Berg%2C+Jenny&rft.au=Gannedahl%2C+Mia&rft.date=2017-07-01&rft.eissn=1477-0970&rft.volume=23&rft.issue=8&rft.spage=1123&rft_id=info:doi/10.1177%2F1352458517694432&rft_id=info%3Apmid%2F28273775&rft_id=info%3Apmid%2F28273775&rft.externalDocID=28273775 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0970&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0970&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0970&client=summon |